Skip to content
healthcare.dev

EVEROLIMUS

NDC 60219-2280, everolimus, tablet, for suspension, from Amneal Pharmaceuticals NY LLC.

Product NDC
60219-2280
Status
Listed
Labeler
Amneal Pharmaceuticals NY LLC
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218863
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60219-2280 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS3 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
60219-2280-2602192280024 BLISTER PACK in 1 CARTON (60219-2280-2) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (60219-2280-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6f1ae129-c21e-4c25-84c1-a6757d9a7eb2

Use it

Look up 60219-2280 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60219-2280 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60219-2280. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.